| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.271 | 30.309 | 17.026 | 24.205 | 24.991 | 15.596 | 15.368 | 22.151 | 26.532 | 30.977 |
| Total Income - EUR | 16.280 | 30.309 | 17.026 | 24.205 | 24.992 | 16.861 | 15.368 | 22.152 | 26.533 | 30.980 |
| Total Expenses - EUR | 13.041 | 24.741 | 16.815 | 19.376 | 22.252 | 12.100 | 15.183 | 19.807 | 20.752 | 25.637 |
| Gross Profit/Loss - EUR | 3.239 | 5.568 | 211 | 4.830 | 2.740 | 4.761 | 185 | 2.345 | 5.781 | 5.343 |
| Net Profit/Loss - EUR | 2.751 | 5.064 | 40 | 4.588 | 2.483 | 4.655 | 185 | 2.222 | 5.520 | 5.040 |
| Employees | 2 | 2 | 2 | 4 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Ab Medprest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 681 | 469 | 299 | 133 | 0 | 60 | 32 | 5 | 61 | 33 |
| Current Assets | 3.210 | 8.452 | 7.952 | 10.921 | 13.464 | 13.377 | 10.532 | 8.956 | 11.566 | 13.011 |
| Inventories | 22 | 10 | 33 | 41 | 18 | 28 | 3 | 0 | 0 | 0 |
| Receivables | 1.386 | 3.210 | 785 | 2.405 | 1.553 | 1.914 | 2.292 | 1.855 | 4.247 | 2.710 |
| Cash | 1.803 | 5.231 | 7.134 | 8.475 | 11.893 | 11.434 | 8.237 | 7.101 | 7.319 | 10.301 |
| Shareholders Funds | 2.796 | 7.831 | 7.739 | 10.036 | 12.325 | 12.611 | 10.697 | 2.488 | 5.566 | 5.080 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.130 | 1.090 | 640 | 1.018 | 1.148 | 825 | 1.097 | 6.473 | 6.061 | 7.964 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Ab Medprest S.r.l.